Clinical Trial Update: Phosphatase Inhibition by Intracoronary Gene Therapy in Subjects With Non-Ischemic NYHA Class III Heart Failure [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating phosphatase-inhibiting intracoronary gene therapy in subjects with non-ischemic NYHA Class III heart failure. The study status i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Phosphatase inhibition intracoronary gene therapy

Snippet

Sponsor: AskBio Inc | Conditions: Congestive Heart Failure | Phase 2 | Status: ACTIVE_NOT_RECRUITING